Skip to main content
SpringerLink
Log in

Effects of prostacyclin (PGI2) and adenosine (ASN) on total and regional blood flow of isolated, collateralized dog hearts

  • Original Contributions
  • Published:
Basic Research in Cardiology Aims and scope Submit manuscript

Summary

Dogs were subjected to chronic occlusion of the left circumflex and the right coronary artery by ameroid-type constrictors 4–5 weeks before the experiments. The hearts were isolated, fibrillated and perfused with blood (100 mmHg) from a support dog. Total and regional myocardial blood flow as well as peripheral coronary pressure (circumflex artery) were determined before and during infusion of PGI2 and ASN into the isolated hearts. Both drugs increased total and regional blood flow to all parts of the myocardium in a dose-dependent manner, PGI2 being 2–3 times more potent than ASN. The perfusion pressure for the collateral-dependent myocardium, the peripheral coronary pressure, decreased following high doses of both drugs. For PGI2 a dose level existed where total flow was increased, while peripheral coronary pressure remained unaffected. After termination of the infusion of PGI2, peripheral coronary pressure rose above predrug level with the total blood flow still being elevated. These findings indicate a PGI2-induced dilatation of collateral vessels. In general, the hemodynamic profile within the isolated hearts and the support dogs was characterized by the pronounced vasodilatory effects of PGI2 on arterioles. However, these effects did not deteriorate further the nonhomogenous blood flow distribution in the collateralized portions of the myocardium.

The findings suggest that PGI2 is not a specific coronary vasodilator.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Au, T. L. S., G. A. Collins, C. J. Harvie, M. J. A. Walker: The actions of prostaglandins I2 and E2 on arrhythmias produced by coronary occlusion in the rat and dog. Prostaglandins18, 707 (1979).

    Article  PubMed  Google Scholar 

  2. Chapple, D. J., G. J. Dusting, R. Hughes, J. R. Vane: Some direct and reflex cardiovascular actions of prostacyclin (PGI2) and prostaglandin E2 in anaesthetized dogs. Brit. J. Pharmacol.68, 437 (1980).

    Google Scholar 

  3. De Deckere, E. A. M.: Effects of prostaglandins on coronary flow rate and left ventricular work in isolated rat heart. Europ. J. Pharmacol.58, 211 (1979).

    Article  Google Scholar 

  4. De Deckere, E. A. M., D. H. Nugteren and F. Ten Hoor: Prostacyclin is the major prostaglandin released from the isolated perfused rabbit and rat heart. Nature268, 160 (1977).

    PubMed  Google Scholar 

  5. Dembinska-Kiec, A., W. Rücker, P. S. Schönhöfer: Effects of PGI2 and PGI analogues on cAMP levels in cultured endothelial and smooth muscle cells derived from bovine arteries. Naunyn-Schmiedeberg's Arch. Pharmacol.311, 67 (1980).

    Article  Google Scholar 

  6. Dix, R. K., G. J. Kelliher, N. Jurkiewicz, Th. Lawrence: The influence of prostacyclin on coronary occlusion induced arrhythmia in cats. Prostaglandins Med.3, 173 (1979).

    Article  PubMed  Google Scholar 

  7. Dusting, G. J., D. J. Chapple, R. Hughes, S. Moncada, J. R. Vane: Prostacyclin (PGI2) induces coronary vasodilation in anaesthetized dogs. Cardiovasc. Res.12, 720 (1978).

    PubMed  Google Scholar 

  8. Dusting, G. J., S. Moncada, J. R. Vane: Prostacyclin (PGX) is the endogenous metabolite responsible for relaxation of coronary arteries induced by arachidonic acid. Prostaglandins13, 3 (1977).

    Article  PubMed  Google Scholar 

  9. Dusting, G. J., S. Moncada, J. R. Vane: Prostacyclin (PGI2) is a weak contractor of coronary arteries of the pig. Europ. J. Pharmacol.45, 301 (1977).

    Article  Google Scholar 

  10. Dusting, G. J., S. Moncada, J. R. Vane: Disappearance of prostacyclin (PGI2) in the circulation of the dog. Brit. J. Pharmacol.62, 414 P. (1978).

  11. Fiedler, V. B., J. Scholtholt: Haemodynamic effects of molsidomine. Arzneim. Forsch.28, 1605 (1978).

    Google Scholar 

  12. Fitzpatrick, T. M., E. Alter, E. J. Corey, P. W. Ramwell, J. C. Rose, P. A. Kot: Cardiovascular responses to PGI2 (prostacyclin) in the dog. Circulat. Res.42, 192 (1978).

    PubMed  Google Scholar 

  13. Gryglewski, R. J.: Prostacyclin as a circulatory hormone. Biochem. Pharmacol.28, 316 (1979).

    Article  Google Scholar 

  14. Gryglewski, R. J., S. Bunting, S. Moncada, R. J. Flower, J. R. Vane: Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. Prostaglandins12, 685 (1976).

    Article  PubMed  Google Scholar 

  15. Hintze, T. H., E. G. Martin, E. J. Messina, G. Kaley: Prostacyclin (PGI2) elicits reflex bradycardia in dogs: evidence for vagal mediation. Proc. Soc. Exp. Biol. Med.162, 96 (1979).

    PubMed  Google Scholar 

  16. Hofmann, M., M. Hofmann, G. Stämmler, W. Schaper: Die Wirkung von Prostacyclin (PGI2) bei experimentellem Koronarverschluß. Z. Kardiol.69, 194, Abstr. 68 (1980).

    Google Scholar 

  17. Hyman, A. L., P. J. Kadowitz, W. E. M. Lands, C. G. Crawford, J. Fried, J. Barton: Coronary vasodilator activity of 13, 14-dehydroprostacyclin methyl ester: comparison with prostacyclin and other prostanoids. Proc. Natl. Acad. Sci.75, 3522 (1978).

    PubMed  Google Scholar 

  18. Ito, T., K. Ogawa, I. Enomoto, H. Hashimoto, I. Kai, T. Satake: Comparison of the effects of PGI2 and PGE1 on coronary and systemic hemodynamics and coronary arterial nucleotide levels in dogs. Adv. Prostaglandin Thromboxane Res.7, Ed.: B. Samuelsson, P. W. Ramwell and R. Paoletti. p. 641 Raven Press (New York 1980).

    Google Scholar 

  19. Jentzer, J. H., E. H. Sonnenblick, E. S. Kirk: Specificity of prostacyclin as a coronary artery vasodilator. Clin. Res.27, 177A (1979).

    Google Scholar 

  20. Jugdutt, B. I., G. M. Hutchins, B. H. Bulkley, L. C. Becker: Infarct size reduction by prostacyclin after coronary occlusion in conscious dogs. Clin. Res.27, 177A (1979).

    Google Scholar 

  21. Kaley, G., E. J. Messina, T. H. Hintze, A. M. Roberts, E. G. Martin, B. L. Slomiany: Effects of the metabolites of arachidonic acid on coronary blood flow. Prostaglandins13, 1011 (1977).

    Article  Google Scholar 

  22. Karmazyn, M., D. F. Horrobin, M. S. Manku, S. C. Cunnane, R. A. Karmali, A. I. Ally, R. O. Morgan, K. C. Nicolaou, W. E. Barnette: Effects of prostacyclin on perfusion pressure, electrical activity, rate and force of contraction in isolated rat and rabbit hearts. Life Sci.22, 2079 (1978).

    Article  PubMed  Google Scholar 

  23. Kukovetz, W. R., S. Holzmann, A. Wurm, G. Pöch: Prostacyclin increases cAMP in coronary arteries. J. Cyclic Nucleotide Res.5, 469 (1979).

    PubMed  Google Scholar 

  24. Lefer, A. M., M. L. Ogletree, J. B. Smith, M. J. Silver, K. C. Nicolaou, W. E. Barnette, G. P. Gasic: Prostacyclin: a potentially valuable agent for preserving myocardial tissue in acute myocardial ischemia. Science200, 52 (1978).

    PubMed  Google Scholar 

  25. Link, H. B., R. Rösen, K. Schrör: Prostacyclin: a potent coronary dilating agent in rat isolated heart. J. Physiol.284, 106 P. (1978).

  26. Miller, O. V., J. W. Aiken, D. P. Hemker, R. J. Shebuski, R. R. Gorman: Prostacyclin stimulation of dog arterial cyclic AMP levels. Prostaglandins18, 915 (1979).

    Article  PubMed  Google Scholar 

  27. Moncada, S., R. J. Gryglewski, S. Bunting, J. R. Vane: An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature263, 663 (1976).

    PubMed  Google Scholar 

  28. Needleman, P., S. D. Bronson, A. Wyche, M. Sivkoff, K. C. Nicolaou: Cardiac and renal prostaglandin I2. Biosynthesis and biological effects in isolated perfused rabbit tissues. J. Clin. Invest.61, 839 (1978).

    PubMed  Google Scholar 

  29. Nicolaou, K. C., W. E. Barnette, G. P. Gasic, R. L. Magilda, W. J. Sipio: Simple efficient synthesis of prostacyclin (PGI2). J. Chem. Soc. Chem. Commun. 630 (1977).

  30. Ogletree, M. L., A. M. Lefer, J. B. Smith, K. C. Nicolaou: Studies on the protective effect of prostacyclin in acute myocardial ischemia. Europ. J. Pharmacol.56, 95 (1979).

    Article  Google Scholar 

  31. Ogletree, M. L., J. B. Smith, A. M. Lefer: Actions of prostaglandins on isolated perfused cat coronary arteries. Amer. J. Physiol.235, H400 (1978).

    Google Scholar 

  32. Pedersen, A. K.: Cardiac prostacyclin release: stimulation by hypoxia and various agents. Scand. J. Haematol. Suppl.34, 105 (1979).

    Google Scholar 

  33. Ribeiro, L. G. T., L. A. Reduto, T. A. Brandon, A. A. Taylor, D. G. Hopkins, R. R. Miller: Effects of prostacyclin in hemodynamics, regional myocardial blood flow, infarct size and mortality in experimental myocardial infarction. Clin. Res.27, 199 A (1979).

    Google Scholar 

  34. Rothman, M., G. Bergmann, L. Atkinson, P. Richardson, D. Jewitt: Hemodynamic and metabolic effects of prostacyclin in ischemic heart disease. VIIth European Congress of Cardiology, Paris, June 22–26, 1980, Abstr. 1896.

  35. Schaper, W.: Regulation of coronary blood flow. In: The Pathophysiology of Myocardial Perfusion. Ed.: W. Schaper, p. 171, Elsevier/North-Holland, Biomedical Press 1979.

  36. Schaper, W.: Effect of drugs on collateral circulation. In: The Pathophysiology of Myocardial perfusion. Ed.: W. Schaper; p. 471, Elsevier/North-Holland, Biomedical Press 1979.

  37. Schaper, W., B. Wüsten: Collateral circulation. In: The Pathophysiology of Myocardial Perfusion. Ed.: W. Schaper, p. 415, Elsevier/North-Holland, Biomedical Press 1979.

  38. Schölkens, B. A.: Vasopressor response to prostacyclin (PGI2) in anaesthetized rats, rabbits and dogs. Prostaglandins Med.2, 401 (1979).

    Article  PubMed  Google Scholar 

  39. Schölkens, B. A.: Antihypertensive effect of prostacyclin (PGI2) in experimental hypertension and its influence on plasma renin activity in rats. Prostaglandins Med.1, 359 (1978).

    Article  PubMed  Google Scholar 

  40. Schrör, K., S. Moncada: Effects of prostacyclin on coronary circulation, heart rate and myocardial contractile force in isolated hearts of guinea pig and rabbit-comparison with prostaglandin E2. Prostaglandins17, 367 (1979).

    PubMed  Google Scholar 

  41. Schrör, K., P. Rösen: Prostacyclin (PGI2) decreases the cyclic AMP level in coronary arteries. Naunyn-Schmiedeberg's Arch. Pharmacol.306, 101 (1979).

    Article  Google Scholar 

  42. Schrör, K., R. Rösen, H. B. Link, P. Rösen: Physiological and biochemical parameters of prostacyclin action on the heart and coronary vasculature. Adv. Prostglandin Thromboxane Res.7, Ed.: B. Samuelsson, P. W. Ramwell and R. Paoletti. p. 625, Raven Press, (New York 1980).

    Google Scholar 

  43. Szczeklik, A., R. J. Gryglewski, R. Nizankowski, J. Musial, R. Pieton, J. Mruk: Circulatory and anti-platelet effect of intravenous prostacyclin in healthy man. Pharmacol. Res. Commun.10, 545 (1978).

    PubMed  Google Scholar 

  44. Tyrell, N., R. Loeb, P. W. Ramwell: Response of the circular and longitudinal coronary muscle to prostacyclin. Fourth International Prostaglandin Conference, Washington, D. C., May 27–31, 1979. Book of abstracts, p. 117.

  45. Vahouny, G. V., H. S. Bolton, R. Chanderbhan, R. W. Bryant, J. M. Bailey, W. B. Weglicki: Prostaglandin synthesis by cardiac cells. Circulation Part II, 60, Nr.4, II, 225 (1979).

  46. Waldmann, H. M., I. Alter, P. A. Kot, J. C. Rose, P. W. Ramwell: Effect of lung transit on systemic depressor responses to arachidonic acid and prostacyclin in dogs. J. Pharmacol. Exp. Ther.204, 289 (1978).

    PubMed  Google Scholar 

  47. Wennmalm, A.: Prostacyclin-dependent coronary vasodilation in rabbit and guinea pig hearts. Acta Physiol. Scand.106, 47 (1979).

    PubMed  Google Scholar 

  48. Winkler, B.: The tracer microsphere method. In: The Pathophysiology of Myocardial perfusion. Ed.: W. Schaper; p. 13, Elsevier/North-Holland, Biomedical Press 1979.

  49. Wüsten, B.: Biophysics of coronary artery narrowing. In: The Pathophysiology of Myocardial Perfusion. Ed.: W. Schaper, p. 285, Elsevier/North-Holland, Biomedical Press 1979.

Download references

Author information

Author notes

  1. J. Scholtholt

    Present address: Hoechst AG and Cassella AG, 6230, Frankfurt/Main 80, Germany

Authors and Affiliations

  1. Hoechst AG and Cassella AG, 6230, Frankfurt/Main 80, Germany

    H. Birringer, V. B. Fiedler & B. Schölkens

Authors
  1. J. Scholtholt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Birringer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. V. B. Fiedler
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Schölkens
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Scholtholt, J., Birringer, H., Fiedler, V.B. et al. Effects of prostacyclin (PGI2) and adenosine (ASN) on total and regional blood flow of isolated, collateralized dog hearts. Basic Res Cardiol 76, 313–327 (1981). https://doi.org/10.1007/BF01907775

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01907775

Key words

Search

Navigation